Samira Mubareka, MD

Scientist
Sunnybrook Health Sciences Centre, University of Toronto, Canada

Disclosure(s): Pfizer: Grant/Research Support

Poster(s):

• (P-40) Impact of case and control selection on influenza vaccine effectiveness (VE) among adults aged 40 years and older hospitalized with acute respiratory illness (ARI) during 2022-2023 using a test negative design (TND): secondary analysis of the North America multi-specimen study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1906) Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario, Canada.
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT